Use of Prophylactic Antibiotics to Prevent Urinary Tract Infection after Urodynamic Testing and Cystoscopy in Women: A Practice Pattern Study

OBJECTIVES: The objective of the study was to determine practice patterns of prescribing prophylactic antibiotics against urinary tract infection (UTI) for urodynamic studies (UDS) and outpatient cystoscopy in women. DESIGN: A cross-sectional survey study was conducted of North American female pelvi...

Full description

Bibliographic Details
Main Authors: Benseler, A. (Author), McDermott, C.D (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
Online Access:View Fulltext in Publisher
LEADER 03157nam a2200421Ia 4500
001 10.1159-000524266
008 220630s2022 CNT 000 0 und d
020 |a 1423002X (ISSN) 
245 1 0 |a Use of Prophylactic Antibiotics to Prevent Urinary Tract Infection after Urodynamic Testing and Cystoscopy in Women: A Practice Pattern Study 
260 0 |b NLM (Medline)  |c 2022 
520 3 |a OBJECTIVES: The objective of the study was to determine practice patterns of prescribing prophylactic antibiotics against urinary tract infection (UTI) for urodynamic studies (UDS) and outpatient cystoscopy in women. DESIGN: A cross-sectional survey study was conducted of North American female pelvic medicine and reconstructive specialists (FPMRS). METHODS: An online survey was used to assess prophylactic prescribing patterns of FPMRS that perform UDS and outpatient cystoscopy. This survey was developed and then electronically disseminated through the American Urogynecologic Society to 699 eligible physicians. RESULTS: A total of 138 surveys were completed. Approximately half of physicians did not prescribe any antibiotic prophylaxis for UDS or for cystoscopy (54% and 43%, respectively). For patients with perceived risk factors (recurrent UTIs, immunosuppression, known neurogenic lower urinary tract dysfunction, indwelling catheter use, elevated postvoid residual/bladder outlet obstruction, genitourinary anomalies, and diabetes), 32% and 41% of physicians prescribed antibiotic prophylaxis for UDS and cystoscopy, respectively. A minority of physicians always prescribed antibiotics for UDS and cystoscopy (13% and 17%, respectively). LIMITATIONS: The response rate was a limitation of the study; however, this rate is in keeping with other physician survey studies published within this subspecialty. Selection and response biases may have contributed to the results of this survey study. CONCLUSION: There was no uniform approach to UTI prophylaxis for UDS and outpatient cystoscopy in women which reflects the lack of current guidelines and the low level of evidence on which they are based. This nonuniform practice calls for more research to better define an evidence-based standard of care. © 2022 The Author(s). Published by S. Karger AG, Basel. 
650 0 4 |a adverse event 
650 0 4 |a Anti-Bacterial Agents 
650 0 4 |a antibiotic prophylaxis 
650 0 4 |a Antibiotic prophylaxis 
650 0 4 |a Antibiotic Prophylaxis 
650 0 4 |a antiinfective agent 
650 0 4 |a Cross-Sectional Studies 
650 0 4 |a cross-sectional study 
650 0 4 |a cystoscopy 
650 0 4 |a Cystoscopy 
650 0 4 |a Cystoscopy 
650 0 4 |a female 
650 0 4 |a Female 
650 0 4 |a human 
650 0 4 |a Humans 
650 0 4 |a procedures 
650 0 4 |a urinary tract infection 
650 0 4 |a Urinary tract infection 
650 0 4 |a Urinary Tract Infections 
650 0 4 |a urodynamics 
650 0 4 |a Urodynamics 
650 0 4 |a Urodynamics 
650 0 4 |a Women 
700 1 0 |a Benseler, A.  |e author 
700 1 0 |a McDermott, C.D.  |e author 
773 |t Gynecologic and obstetric investigation 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1159/000524266